Bristol-Myers Squibb Company News Headlines

BMY 
$50.885
*  
0.235
0.46%
Get BMY Alerts
*Delayed - data as of Jul. 31, 2014 14:47 ET  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BMY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Bristol-Myers Says Study of Melanoma Treatment Shows Favorable Comparison
6/24/2014 5:55:00 PM - Dow Jones Business News

Bristol-Myers Is Almost In The 'Buy Zone'
6/24/2014 9:20:00 AM - Seeking Alpha

Bristol-Myers Expands Access To Clinical Trial Data - Quick Facts
6/24/2014 8:19:00 AM - RTT News

XLV, AMGN, BMY, UNH: Large Outflows Detected at ETF
6/23/2014 11:21:50 AM - BNK Invest

Analyzing The Hepatitis C Market Size: Why It May Have Bullish Implications For Gilead
6/23/2014 11:15:00 AM - Seeking Alpha

DIY Dividend Investors Club (Part 4): Stocks To Watch And To Buy Now (Healthcare)
6/23/2014 1:00:00 AM - Seeking Alpha

Weekly Market Wrap: June 20, 2014
6/20/2014 4:52:13 PM - BNK Invest

Alkermes' Aripiprazole Lauroxil Looks Promising - Analyst Blog
6/19/2014 11:40:00 AM - Zacks.com

Daily Dividend Report: USB, FITB, BMY, O, AGNC, TWO, CNW, MTGE
6/18/2014 3:54:29 PM - BNK Invest

Hepatitis C May Give A Big Boost To These Drug Stocks - If The FDA Approves
6/17/2014 1:32:00 PM - Seeking Alpha

Gilead's HCV Combination Therapy Data Looks Promising - Analyst Blog
6/16/2014 11:40:00 AM - Zacks.com

6 Healthcare Dividend Dogs Dope 10% To 44% June Upsides
6/15/2014 12:41:00 AM - Seeking Alpha

Bristol-Myers Suffers a Legal Setback - Analyst Blog
6/13/2014 11:30:00 AM - Zacks.com

Cramer's Lightning Round - Isis Pharmaceuticals Has One Of The Best Pipelines In The Industry (6/12/14)
6/13/2014 6:33:00 AM - Seeking Alpha

Appeals Court Backs Teva Over Hepatitis Drug's Patent
6/12/2014 4:41:00 PM - Dow Jones Business News

Why Big Pharma Has No Interest In Achillion's 'Me Too' Hepatitis C Drug
6/12/2014 8:30:00 AM - Seeking Alpha

Cramer's Lightning Round - Trains Are On The Rails (6/11/14)
6/12/2014 4:47:00 AM - Seeking Alpha

Bristol-Myers' RA Drug Orencia Encouraging - Analyst Blog
6/11/2014 6:10:00 PM - Zacks.com

Big Pharma Looks For New Models
6/10/2014 4:02:00 PM - Seeking Alpha

Bristol-Myers To Present At Goldman Sachs Conference; Webcast At 1:40 PM ET
6/10/2014 12:40:00 PM - RTT News

Gilead Sciences: Killing The Competition With Sovaldi; But Does This Make Gilead A One-Trick Pony?
6/9/2014 6:08:00 PM - Seeking Alpha

Merck to Buy Idenix for $3.85 Billion -- 6th Update
6/9/2014 12:58:00 PM - Dow Jones Business News

Bristol-Myers Squibb Appoints Giovanni Caforio COO - Quick Facts
6/9/2014 8:27:00 AM - RTT News

Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
6/6/2014 1:45:00 PM - Seeking Alpha

Bristol-Myers Focuses on India - Analyst Blog
6/5/2014 5:47:00 PM - Zacks.com